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Neoangiogenesis and Blood-brain Barrier Dysfunction in Human TSC Brain
Lesions
Kimberly Sansalone, Pelin Dilsiz, Howard Weiner, Orrin Devinsky, Delia M. Talos*

Introduction: Tuberous sclerosis complex (TSC) is a genetic disorder characterized by
the presence of multiple benign tumors throughout the body and brain. Patients with
TSC experience severe cognitive dysfunction and therapy-resistant seizures, which can
be associated with refractory epilepsy and poor developmental outcomes. We
hypothesize that neoangiogenesis, disruption of the blood-brain barrier, and leakage of
serum proteins into the brain parenchyma play vital roles in the pathogenesis of TSC.

Methods: In order to assess blood-brain barrier integrity, cortical tissue samples from
TSC patients with intractable seizures, non-TSC patients with therapy-resistant
epilepsy, and control subjects were immunolabeled for the serum protein fibrinogen, the
adherens junction protein V-cadherin, and the tight junction protein occludin. Lectin was
used to visualize blood vessels. Quantification was performed to assess average blood
vessel segment length and branching. The fraction of membrane-associated V-cadherin
and occludin, relative to the blood vessel surface area represented by lectin, was also
analyzed.

Results: The average length of blood vessel segments and the average number of
branch nodes were significantly increased in TSC compared to epilepsy and control.
The average surface area fraction of V-cadherin and occludin was significantly
decreased in TSC compared to control. In addition, fibrinogen staining outside of the
blood vessels was extensive in both TSC and epilepsy. These results confirm our
hypothesis, suggesting blood-brain barrier dysfunction in TSC, with disease-specific
neoangiogenic mechanisms in TSC.

Discussion: Our results show increased blood-brain barrier permeability and increased
vascular proliferation in TSC. These findings are likely due to decreased expression of
tight junctions and adherens junctions in TSC cortical tissue. These results suggest that
antiangiogenic therapies targeting the blood-brain barrier may offer a novel approach to
preventing epileptogenesis in patients with TSC.

